August 2021

Nkarta reveals plans for new headquarters in San Francisco, production site

Nkarta Therapeutics Inc. (NASDAQ: NKTX) will move to an 88,000-square-foot facility that will not only serve as a new headquarters, but will also serve for the research, advancement and long-term advertising production of its mobile treatment line. The facility will be a multi-product production site and is expected to go live until the end of 2023, said Nkarta. At full capacity, the facility is expected to produce a multi-media advertising source.

Nkarta reveals plans for new headquarters in San Francisco, production site Read More »